Linguistic Systems is MBC's first language translation member

Linguistic Systems, Inc. (LSI), a leading provider of language translation services, today announced that it has joined the Massachusetts Biotechnology Council (MBC) as the first language translation member in the organization. LSI’s participation in MBC is a sign of the upward rise in international business taking place across the biotechnology industry. LSI continues to develop innovative, creative solutions for its biotech clients, and now with this membership, LSI will deliver those industry leading solutions to the widening biotech market of MBC’s members.

“We are thrilled to be a part of this expanding biotechnology community,” said Martin Roberts, President of Linguistic Systems, Inc. “Language translation has a pivotal role in the innovative life science community, and we welcome the opportunity to share our expertise and resolve the MBC members’ language translation needs. At LSI we are proud of our proficiency in moving ideas and business matters with meticulous care through the barriers created by different languages and cultures.”

Since 1967, LSI has been resolving clients’ language translation needs by providing a customized strategy that helps their clients efficiently accomplish both short and long-term objectives. By successfully delivering on the promise, LSI has grown to be one of the largest translation service companies in the United States, with a talent pool of more than 4,000 translators who translate into their native languages. These translation experts include highly trained scientists, engineers, lawyers, and other bilingual professionals.

“We are excited to have LSI join our membership,” said Robert Coughlin, President & CEO of the Massachusetts Biotechnology Council. “The biotechnology industry is becoming increasingly global in its collaborations and partnerships, and we are excited to grow our membership alongside these trends.”

LSI has provided translation services to over half of the Fortune 500 companies and most of the Fortune 100. Among their clients are Johnson & Johnson, Pfizer, Wyeth, Merck & Co, Inc., GlaxoSmithKline, Abbot Labs, Bristol Myers-Squibb, Novartis, USP, Biogen-Idec, Genzyme, and Amgen.

www.linguist.com